Pharma Journalist -

Exclusive Opportunity: Partner With the Leaders Defining the Future of the Digital Lab If your commercial strategy depends on reaching senior R&D leaders who are actively…
Read More...

Idorsia Ltd has entered into an exclusive distribution and commercialization agreement with Pharmalink Drug Store L.L.C to bring its insomnia treatment QUVIVIQ™ (daridorexant) to…
Read More...

Vaccine manufacturer CSL Seqirus has announced a long-term partnership with the Pan American Health Organization (PAHO) Regional Revolving Fund aimed at strengthening influenza vaccine…
Read More...

Danish pharmaceutical company Novo Nordisk has announced a new agreement with telehealth platform Hims & Hers Health aimed at expanding patient access to its FDA-approved…
Read More...

The U.S. Food and Drug Administration has approved an expanded indication for Wellcovorin to treat patients with cerebral folate deficiency linked to variants in the Folate Receptor 1…
Read More...

GSK plc has entered into a licensing agreement with Alfasigma S.p.A. granting the Italian pharmaceutical company exclusive global rights to develop, manufacture, and commercialize…
Read More...

The U.S. Food and Drug Administration has announced a new regulatory initiative aimed at accelerating the development of biosimilar medicines while reducing costs for drug manufacturers…
Read More...

Pharmaceutical company GSK plc has entered into a licensing agreement with Italian drugmaker Alfasigma S.p.A. granting the latter worldwide exclusive rights to develop, manufacture and…
Read More...

Clinical-stage biotechnology company NewcelX Ltd. has announced a collaborative research agreement with immunology-focused firm Eledon Pharmaceuticals aimed at advancing potential new…
Read More...

Biotechnology company Liberate Bio, Inc. has secured new intellectual property licenses aimed at advancing next-generation cell therapies that reprogram immune cells directly inside the…
Read More...